June 21, 2008
Sen. Chuck Grassley
135 Hart Senate Bldg.
Washington, DC
20510-1501
via email
Dear Senator Grassley:
Regarding the June 21, 2008 article in my local newspaper, the Philadelphia Inquirer, entitled “Glaxo’s Paxil faces scrutiny on the Hill ” (http://www.philly.com/philly/business/20624784.html ), I note your concerns that Glaxo/GSK may have withheld Paxil adverse events information on suicidal behavior from regulators.
As a physician...
Post new comment